This test is most useful if any of these apply to you.
If you have sudden bloody diarrhea, severe stomach cramps, or a child in your household is sick after eating undercooked beef or contaminated produce, this is the test that answers the question that matters most: is a toxin-producing strain of E. coli the cause? The answer changes what doctors do next, what medications to avoid, and how closely your kidneys need to be watched.
Shiga toxin-producing E. coli (STEC) is not a chronic biomarker like cholesterol. It is a direct test for an active, often fast-moving infection that can escalate from diarrhea to kidney failure within days. Knowing whether STEC is driving your illness helps you and your clinician act on the right things and avoid the wrong ones.
The test looks for either the Shiga toxin itself or the genes (called stx genes) that the bacteria use to make it. Modern stool testing uses PCR (a technique that finds the bacteria's DNA), which is more sensitive than older enzyme tests and can also identify which toxin subtype is present. PCR is sensitive enough that two negative follow-up samples can be used to confirm the infection has cleared.
Not all STEC strains carry the same risk. The well-known O157:H7 strain causes severe illness, but many non-O157 strains also cause outbreaks and serious disease. Public health agencies track a group often called the 'Big Six' non-O157 serogroups (O26, O45, O103, O111, O121, O145). Other emerging serogroups such as O80 are also clinically important and almost always carry stx2. Subtype matters too: strains producing stx2, especially stx2a, are most strongly linked to bloody diarrhea and kidney complications.
In a national surveillance study from New Zealand covering 5,769 cases, about one in four people with STEC developed severe illness. Across many series, roughly 25 to 50 percent of cases involve bloody stool. Hemolytic uremic syndrome (HUS), a condition where the toxin damages small blood vessels in the kidneys, develops in roughly 5 to 15 percent of STEC cases overall and in 15 to 20 percent of high-risk pediatric infections. Rates as high as 22 percent have been reported in selected pediatric cohorts of culture-positive cases.
HUS is the most feared complication. It is a leading cause of acute kidney failure in young children. In a Finnish study of 262 children with STEC infection, 22 percent developed HUS. Of those, 63 percent required dialysis and 33 percent had significant neurological symptoms.
A long-term study from Wales followed 1,245 people exposed to STEC O157 for years after their infection. Compared to the general population, they had about 1.9 times the risk of kidney problems (95% confidence interval 1.1 to 3.3), 1.7 times the risk of ongoing gastrointestinal problems (95% confidence interval 1.1 to 2.5), and 1.4 times the risk of respiratory issues, occurring 3.4 to 11 years after infection.
For those who developed HUS, the long-term risks were even higher: about 7.7 times the risk of gastrointestinal complications, 5.5 times the kidney risk, and 5.1 times the cardiac risk. A separate study of 281 STEC-HUS patients followed for a median of 12 years found that 51 percent had some form of chronic kidney disease. Most of that signal came from mild stage 1 disease (about 37 percent of patients had only microalbuminuria with preserved kidney function), while about 14 percent progressed to more advanced stage 2 to 5 kidney disease.
Children under 3 to 5 years old are consistently the most affected and at highest risk for HUS. In a Finnish analysis, age under 3 carried about 2.4 times the odds of developing HUS, while infection with stx2 carried 9.7 times the odds and stx2a carried 16.6 times the odds. In a UK study of 3,323 STEC O157 cases, children aged 1 to 4 had 8.65 times the odds of typical HUS compared to other age groups.
Older adults are also vulnerable. In the 2011 German O104:H4 outbreak, older patients were more likely to have bloody diarrhea and women had slightly higher odds of developing HUS than men.
This is one of the most important reasons to know whether STEC is the cause of an illness. A meta-analysis of 17 studies covering 1,896 patients found that overall, antibiotic use was not significantly associated with HUS (pooled odds ratio 1.33, 95% confidence interval 0.89 to 1.99). However, when the analysis was restricted to low-bias studies that used standard HUS definitions, antibiotic use roughly doubled the odds (odds ratio 2.24, 95% confidence interval 1.45 to 3.46). In the UK study, beta-lactam antibiotic use was associated with substantially higher odds of HUS, although more recent pooled estimates put the risk closer to about 2.4 times.
The proposed mechanism is that certain antibiotics stress the bacteria and trigger them to release more toxin. Guidelines now recommend avoiding routine antibiotics in suspected STEC diarrhea, which is why getting an accurate diagnosis quickly is so important. The evidence is not uniform across drug classes: some studies suggest fosfomycin may be protective and that bacteriostatic agents such as azithromycin may be safer, but this remains an area of active research and the default recommendation is still to avoid empirical antibiotics.
Cattle and other ruminants are the main reservoirs. Most human infections trace back to contaminated beef, dairy products, leafy greens and produce, untreated water, or direct contact with farm animals. A US study identified eating lettuce, tomatoes, or food from fast-food restaurants as significant exposure routes for non-O157 STEC. A French outbreak in 2011 was linked to organic fenugreek sprouts.
Living in ruminant-dense areas raises infection risk even without direct animal contact, suggesting environmental spread through water, dust, or local food supply chains.
A German cohort of 389 people followed after the 2011 O104:H4 outbreak showed that the rate of irritable bowel syndrome rose from 9.8 percent before infection to 25.3 percent at 12 months. Among those who had no prior IBS, 16.9 percent developed new IBS within a year. STEC can also cause acute encephalopathy, a serious brain inflammation that requires prompt recognition.
The yield of stool testing is highest early in the illness and falls daily after diarrhea starts, so testing within the first several days of symptoms and before any antibiotics are started gives the best chance of detection. The toxin and bacteria can clear from stool quickly, especially as the infection resolves on its own. If you have ongoing or recent severe diarrhea, especially if it is bloody, do not wait.
For people whose stool samples come back negative late in the illness, blood-based testing for antibodies against O-polysaccharide antigens can help confirm STEC was the cause. CDC-validated serology covers O157 and O111, and newer glycoprotein-based assays extend coverage to additional serogroups such as O145. Modern serology can pick up infection even when stool testing misses it.
Because STEC measures an active infection rather than a chronic biological process, the meaningful retest pattern is different from most blood markers. A positive result should be followed by clinical monitoring (kidney function, blood counts, hydration) during the acute phase, and clearance testing afterward if confirmation matters for return to work, food handling, or daycare.
Two consecutive negative PCR samples are generally enough to demonstrate the infection has cleared. People who carry STEC without symptoms can still shed bacteria, and shedding duration varies. If you work in food service, healthcare, or childcare, your local public health authority will likely want documentation of clearance before you return.
A positive STEC result is a signal to act on several fronts at once. First, focus on hydration and supportive care. Second, avoid antibiotics unless a specialist explicitly recommends them for a specific reason. Third, request close monitoring of kidney function, complete blood count, and blood smear during the first 5 to 10 days after diarrhea onset, since this is when HUS typically develops.
If clinical signs point toward HUS (decreased urine output, pallor, easy bruising, swelling, confusion), nephrology evaluation is warranted urgently. Also notify your local public health department: STEC is a reportable infection, and identifying the source helps protect others who may have been exposed.
Several factors affect test accuracy. Sampling more than a week after symptoms began may produce a false negative because the bacteria and toxin may no longer be detectable in stool. Recent antibiotic use can suppress bacterial detection. PCR testing on a multiplex gastrointestinal panel sometimes finds STEC genes in people with very mild or no symptoms, particularly low-virulence strains that may not require the same response as high-risk strains.
Older enzyme immunoassay tests are less sensitive than PCR, so a negative EIA result does not fully rule out STEC if clinical suspicion is high. If the stool test is negative but symptoms strongly suggest STEC, especially with bloody diarrhea or signs of HUS, follow-up with PCR or serology is appropriate.
Shiga Toxin Escherichia Coli is best interpreted alongside these tests.